+

WO2002052003A3 - Regulation du canal calcium humain - Google Patents

Regulation du canal calcium humain Download PDF

Info

Publication number
WO2002052003A3
WO2002052003A3 PCT/EP2001/015088 EP0115088W WO02052003A3 WO 2002052003 A3 WO2002052003 A3 WO 2002052003A3 EP 0115088 W EP0115088 W EP 0115088W WO 02052003 A3 WO02052003 A3 WO 02052003A3
Authority
WO
WIPO (PCT)
Prior art keywords
human calcium
calcium channel
regulation
disorders
reagents
Prior art date
Application number
PCT/EP2001/015088
Other languages
English (en)
Other versions
WO2002052003A2 (fr
Inventor
Alex Smolyar
Original Assignee
Bayer Ag
Alex Smolyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Alex Smolyar filed Critical Bayer Ag
Publication of WO2002052003A2 publication Critical patent/WO2002052003A2/fr
Publication of WO2002052003A3 publication Critical patent/WO2002052003A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des réactifs régulant les canaux calcium humains et des réactifs se liant à des produits géniques de type canal calcium humain, qui peuvent jouer un rôle dans la prévention, l'amélioration ou l'atténuation de dysfonctionnements ou de maladies comprenant notamment, mais pas exclusivement, le cancer, des troubles du SNC, des troubles cardio-vasculaires et des affections hématologiques.
PCT/EP2001/015088 2000-12-26 2001-12-19 Regulation du canal calcium humain WO2002052003A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25729700P 2000-12-26 2000-12-26
US60/257,297 2000-12-26
US28011301P 2001-04-02 2001-04-02
US60/280,113 2001-04-02

Publications (2)

Publication Number Publication Date
WO2002052003A2 WO2002052003A2 (fr) 2002-07-04
WO2002052003A3 true WO2002052003A3 (fr) 2002-12-27

Family

ID=26945881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/015088 WO2002052003A2 (fr) 2000-12-26 2001-12-19 Regulation du canal calcium humain

Country Status (1)

Country Link
WO (1) WO2002052003A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046383A1 (fr) * 1998-03-13 1999-09-16 Brown University Research Foundation Isoforme de canal calcique humain de type n et utilisations
WO2002010389A2 (fr) * 2000-07-28 2002-02-07 Lexicon Genetics Incorporated Nouvelles proteines du canal ionique humain et polynucleotides codant ces dernieres

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046383A1 (fr) * 1998-03-13 1999-09-16 Brown University Research Foundation Isoforme de canal calcique humain de type n et utilisations
WO2002010389A2 (fr) * 2000-07-28 2002-02-07 Lexicon Genetics Incorporated Nouvelles proteines du canal ionique humain et polynucleotides codant ces dernieres

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEIC ACIDS [online] 1 July 2000 (2000-07-01), XP002216680, retrieved from EMBL DATABASE Database accession no. BE141734 *
DATABASE EMBL PROTEIN [online] 1 October 2000 (2000-10-01), XP002216679, retrieved from EMBL DATABASE Database accession no. Q9NT82 *
ISHIBASHI KENICHI ET AL: "Molecular cloning of a novel form (two-repeat) protein related to voltage-gated sodium and calcium channels", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 270, no. 2, 13 April 2000 (2000-04-13), pages 370 - 376, XP002178968, ISSN: 0006-291X *

Also Published As

Publication number Publication date
WO2002052003A2 (fr) 2002-07-04

Similar Documents

Publication Publication Date Title
WO2002070675A3 (fr) Regulation de l'histone acetyltransferase humaine
WO2002072824A3 (fr) Regulation du canal potentiel humain du recepteur transitoire humain
WO2002052003A3 (fr) Regulation du canal calcium humain
WO2002036629A3 (fr) Regulation du precurseur humain des recepteurs de la serotonine
WO2002033080A3 (fr) Regulation du recepteur humain membranaire liant la netrine unc5h-1
WO2002088362A3 (fr) Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine
WO2002062974A3 (fr) Regulation de la proteine humaine elongase hselo1
WO2002057461A3 (fr) Regulation de la metalloprotease a zinc de type adam-ts humaine
WO2002036781A3 (fr) Regulation de la glutathione-s-transferase humaine
WO2003100087A3 (fr) Regulation de nouvelles hydroxylases d'asparagine- humaines
WO2002055712A3 (fr) Regulation de l'alanine aminotransferase humaine
WO2002088363A3 (fr) Regulation de nouvelles prolyl 4-hydroxylases humaines
WO2002081705A3 (fr) Regulation de la proteine humaine de type acetyltransferase gnat
WO2002062975A3 (fr) Regulation de la proteine humaine du type elongase hselo1
WO2003052088A3 (fr) Regulation de la sialyltransferase humaine
WO2002032938A3 (fr) Regulation de la proteine humaine de type pgc-1
WO2002018566A3 (fr) Regulation d'enzyme de type l-asparaginase humaine
WO2002046403A3 (fr) Regulation de la proteine humaine du type 'patched'
WO2003025174A3 (fr) Regulation de la proteine humaine de type mrp1
WO2002072825A3 (fr) Regulation de la proteine humaine de type mrp5
WO2002036613A3 (fr) Regulation de la proteine humaine de type 'patched'
WO2002033097A3 (fr) Regulation de la sulfotransferase humaine
WO2002055681A3 (fr) Regulation de la tau-tubuline kinase humaine
WO2002029049A3 (fr) Regulation du transporteur de monoamine humain dependant du sodium
WO2002030969A3 (fr) Regulation une enzyme humaine de type carboxyesterase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载